Sociedad Americana de Hirudoterapia

Lower Extremity Reconstruction with Free Gracilis Flaps.

Research article published in Journal of reconstructive microsurgery (2016)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosFranco et al. · Journal of reconstructive microsurgery, 2016

Abstract

Background There have been significant advancements in lower extremity reconstruction over the last several decades, and the plastic surgeon's armamentarium has grown to include free muscle and fasciocutaneous flaps along with local perforator and propeller flaps. While we have found a use for a variety of techniques for lower extremity reconstruction, the free gracilis has been our workhorse flap due to the ease of harvest, reliability, and low donor site morbidity. Methods This is a retrospective review of a single surgeon's series of free gracilis flaps utilized for lower extremity reconstruction. Demographic information, comorbidities, outcomes, and secondary procedures were analyzed. Results We identified 24 free gracilis flaps. The duration from injury to free flap coverage was ≤ 7 days in 6 patients, 8-30 days in 11 patients, 31-90 days in 4 patients, and > 90 days in 3 patients. There were 22 (92%) successful flaps and an overall limb salvage rate of 92%. There was one partial flap loss. Two flaps underwent incision and drainage in the operating room for infection. Two patients developed donor site hematomas. Four patients underwent secondary procedures for contouring. Our subset of pediatric patients had 100% flap survival and no secondary procedures at a mean 30-month follow-up. Conclusion This study demonstrates the utility of the free gracilis flap in reconstruction of small- to medium-sized defects of the lower extremity. This flap has a high success rate and a low donor site morbidity. Atrophy of the denervated muscle over time allows for good shoe fit, often obviating the need for secondary contouring procedures.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdolescentAdultAgedChildComorbidityFemaleFollow-Up StudiesFree Tissue FlapsGracilis MuscleGraft SurvivalHumansLower Extremity

Resumen

There have been significant advancements in lower extremity reconstruction over the last several decades, and the plastic surgeon's armamentarium has grown to include free muscle and fasciocutaneous flaps along with local perforator and propeller flaps. While we have found a use for a variety of...

Por qué esto importa para la hirudoterapia

Esta revisión retrospectiva de un solo cirujano sobre 24 colgajos libres de gracilis para reconstrucción de la extremidad inferior reportó una tasa de éxito del colgajo del 92% y una tasa de salvamento de la extremidad del 92%, con baja morbilidad del sitio donante. Su relevancia para la ASH es, en el mejor de los casos, contextual: la reconstrucción de la extremidad inferior con colgajo libre es un contexto quirúrgico en el que las sanguijuelas medicinales se utilizan a veces como coadyuvante para el manejo de la congestión venosa en colgajos comprometidos. Sin embargo, el artículo no menciona sanguijuelas, hirudoterapia, congestión venosa ni coadyuvantes de salvamento del colgajo. El estudio no aporta datos sobre la terapia con sanguijuelas en sí, y la conexión se limita a un contexto clínico compartido en el que la hirudoterapia podría aplicarse ocasionalmente.

Citación

Lower Extremity Reconstruction with Free Gracilis Flaps.

Franco et al. · Journal of reconstructive microsurgery, 2016

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.